ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 135073 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 135073; 2) Community: the network communities that were significantly associated with the response to NSC 135073; 3) Molecule: the relationships between components within communities and NSC 135073; 4) MDR: the compounds that were significantly associated with the NSC 135073.

NSC Compound Enrichment Correlation
NSC 639503 Cyclopentanone, 2-hexylidene-5-[(4-morpholinyl)methyl]-, hydrochloride 0.000463656464354233 0.66090636
NSC 639504 Cyclopentanone, 2-[(dimethylamino)methyl]-5-octylidene-, hydrochloride 0.000463656464354233 0.63313489
NSC 658829 Weisiensin A 0.000463656464354233 0.61657136
NSC 728220 1-(3-Bromo-phenyl)-3-(pyridin-2-ylsulfanyl)-propenone 0.000463656464354233 0.66708252
NSC 614491 8-Cl-cAMP, sodium salt 0.000610795106687085 0.41766512
NSC 651593 Null 0.000610795106687085 0.57396226
NSC 672215 Null 0.000610795106687085 0.46019995
NSC 711737 7H-Thieno[3',4':3,4]cyclopent[1,2-d]oxazole-2,7(1H)-dione, 4,6-dichloro-3a,7a-dihydro-, CIS- 0.000610795106687085 0.48457232
NSC 759274 ARSENIC TRIOXIDE 0.000610795106687085 0.4447623
NSC 33530 Null 0.000613655894404025 0.62969803
Total:99  Current:4    [First] [Prev] [Next] [Last]